Aviva
OGN icon

Aviva’s Organon & Co OGN Stock Holding History

Aviva’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,829
Closed -$205K – 1005
2023
Q2 		$205K Hold
9,829
– – ﹤0.01% 954
2023
Q1 		$231K Sell
9,829
-25,151
-72% -$675K ﹤0.01% 988
2022
Q4 		$977K Sell
34,980
-355
-1% -$9.08K ﹤0.01% 849
2022
Q3 		$827K Sell
35,335
-612
-2% -$18.5K ﹤0.01% 919
2022
Q2 		$1.21M Sell
35,947
-11,136
-24% -$390K 0.01% 942
2022
Q1 		$1.65M Sell
47,083
-53,789
-53% -$1.84M 0.01% 876
2021
Q4 		$3.07M Sell
100,872
-23,865
-19% -$777K 0.01% 693
2021
Q3 		$4.09M Sell
124,737
-13,011
-9% -$416K 0.02% 622
2021
Q2 		$4.17M Buy
+137,748
New +$4.53M 0.02% 637

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Aviva's OGN Position: Q3 2023 in Review

Aviva sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 9,829 shares — an estimated $205K sold.

Aviva first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $4.17M in Q2 2021. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Aviva reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Aviva sold 9,829 Organon & Co shares in Q3 2023, an estimated $205K.
  • Aviva first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Aviva's Organon & Co position peaked at $4.17M in Q2 2021.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Aviva's 13F filing for Q3 2023, filed 13 Nov 2023.